Advertisement

Hyperuricosuric Calcium Urolithiasis

  • Charles Y. C. Pak
Part of the Topics in Bone and Mineral Disorders book series (TOHE)

Abstract

The term “normocalciuric nephrolithiasis” 1 was initially used to describe patients with recurrent Ca urolithiasis in whom a 24-hr urinary Ca was within the normal range. This condition may be subdivided into the different groups listed in Table VIII. Absorptive hypercalciuria Type II was discussed in Chapter 3. Hyperoxaluria will be covered in Chapter 6. The idiopathic group comprises those patients in whom there is no obvious abnormality for stone formation. Some of these patients give a history of low fluid intake. In others, the formation product ratios (FPRs) (limit of metastability) of brushite and Ca oxalate in urine may be significantly reduced. 2 Thus, urinary supersaturation with respect to Ca salts, resulting from the passage of concentrated urine, and deficiency of inhibitors or presence of promoters of nucleation, or both, may be etiologically important in stone formation in the idiopathic group. This chapter will focus principally on Ca stone formation associated with hyperuricosuria.

Keywords

Uric Acid Stone Formation Calcium Oxalate Idiopathic Hypercalciuria Monosodium Urate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pak, C. Y. C, Ohata, ML, Lawrence, E. C., and Snyder, W. 1974. The hypercalciurias: Causes, parathyroid functions and diagnostic criteria. Clin. Invest. 54: 387–400.CrossRefGoogle Scholar
  2. 2.
    Pak, C. Y. C., and Holt, K. 1976. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism 25: 665–673.PubMedCrossRefGoogle Scholar
  3. 3.
    Prien, E. L., and Prien, E. L., Jr. 1968. Composition and structure of urinary stone. Am. J. Med. 45: 654–672.PubMedCrossRefGoogle Scholar
  4. 4.
    Gutman, A. B. 1968. Uric acid nephrolithiasis. Am. J. Med. 45: 756–779.PubMedCrossRefGoogle Scholar
  5. 5.
    Henneman, P. H., Benedict, P. H., Forbes, A. P., and Dudley, H. R. 1958. Idiopathic hypercalciuria. N. Engl. J. Med. 259: 802–807.PubMedCrossRefGoogle Scholar
  6. 6.
    Coe, F. L., and Kavalach, A. G. 1974. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N. Engl. J. Med. 291: 1344–1350.PubMedCrossRefGoogle Scholar
  7. 7.
    Scott, J. T., Dixon, A. St. J., and Bywaters, E. G. L. 1964. Association of hyperuricaemia and gout with hyperparathyroidism. Br. Med. J. 1: 1070–1073.PubMedCrossRefGoogle Scholar
  8. 8.
    Coe, F. L., and Raisen, L. 1973. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet 1: 129–131.PubMedCrossRefGoogle Scholar
  9. 9.
    Pak, C. Y. C., Waters, O., Arnold, L., Holt, K., Cox, C., and Barilla, D. 1977. Mechanism for calcium urolithiasis among patients with hyperurico suria: Supersaturation of urine with respect to monosodium urate. J. Clin. Invest. 59: 426–431.PubMedCrossRefGoogle Scholar
  10. 10.
    Barilla, D. E., and Pak, C. Y. C. 1977. In preparation.Google Scholar
  11. 11.
    Smith, M. J. V. 1977. Placebo vs. allopurinol for renal calculi. J. Urol. In press.Google Scholar
  12. 12.
    Finlayson, B., and Smith, A. 1974. Stability of first dissociable proton of uric acid. J. Chem. Eng. Data 19: 94–97.CrossRefGoogle Scholar
  13. 13.
    Robertson, W. G. 1976. Physical chemical aspects of calcium stone-formation in the urinary tract. In Urolithiasis Research. H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, Eds. Plenum Press, New York, pp. 25–39.CrossRefGoogle Scholar
  14. 14.
    Robertson, W. G., Peacock, M., and Nordin, B. E. C. 1971. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin. Sci. (Oxford) 40: 365–374.Google Scholar
  15. 15.
    Pak, C. Y. C., and Arnold, L. H. 1975. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc. Soc. Exp. Biol. Med. 149: 930–932.PubMedGoogle Scholar
  16. 16.
    Coe, F. L., Lawton, R. L., Goldstein, R. B., and Tembe, V. 1975. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc. Soc. Exp. Biol. Med. 149: 926–929.PubMedGoogle Scholar
  17. 17.
    Pak, C. Y. C., Hayashi, Y., and Arnold, L. H. 1976. Heterogeneous nucleation between urate, calcium phosphate and calcium oxalate. Proc. Soc. Exp. Biol. Med. 153: 83–87.PubMedGoogle Scholar
  18. 18.
    Lonsdale, K. 1968. Human stone. Science 159: 1159–1207.CrossRefGoogle Scholar
  19. 19.
    Lonsdale, K. 1968. Epitaxy as a growth factor in urinary calculi and gallstones. Nature (London) 217: 56–58.Google Scholar
  20. 20.
    Zerwekh, J., and Pak, C. Y. C. 1977. In preparation.Google Scholar
  21. 21.
    Sperling, O., DeVries, A., and Kedem, O. 1965. Studies on the etiology of uric acid lithiasis. IV. Urinary non-dialyzable substances in idiopathic uric acid lithiasis. J. Urol. 94: 286–293.PubMedGoogle Scholar
  22. 22.
    Pak, C. Y. C., Kaplan, R. A., Bone, H., Townsend, J., and Waters, O. 1975. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N. Engl. J. Med. 292: 497–500.PubMedCrossRefGoogle Scholar
  23. 23.
    Coe, F. L. 1977. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. Submitted for publication.Google Scholar
  24. 24.
    Coe, F. L. 1976. Long term prevention of calcium oxalate nephrolithiasis by chronic thiazide and allopurinol administration. Clin. Res. 24: 396A.Google Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • Charles Y. C. Pak
    • 1
  1. 1.The University of Texas Health Science CenterDallasUSA

Personalised recommendations